Member Info for scardey_cat

Abby nicely moving north too...

Boost for @Radiagreen post "confident" and "will now play"...very significant choice of language here.

"Lateral flow tests have a crucial role to play in helping our society and economy return to normal, and I am confident that the AffiDX® test will now play a significant part in this process."

This is very telling. Avacta would not get away with providing this guidance via rns if discussions with UK Gov were not at an advanced stage.

I am confident that the AffiDX® test will now play a significant part in this process."

Yes, Poirot, all we need is one press headline along the lines of:
"Why is the govt still buying inferior Chinese tests when we have a home grown test that has demonstrated 100% sensitivity for identifying infectious individuals"

Will be interesting to see how quickly the Medusa website is updated. They have exclusive DtC, but they can also sell 'professional' non-exclusively.

We've been over 2.70 without orders or MHRA.

"For me, by doing this direct comparison, Avacta have proven that AFFIDX is superior vs the current UK tests, therefore this action, which is very much deliberate, should enable AffiDX to bypass any DHSC requirements - they have proven in a direct clinical comparison that AFFIDX is superior., what more is required? Nothing!"

@Radiagreen
Avacta should publish the full comparison study. That would put huge pressure on the govt to give Affidx EUA for self-use.

"The clinical data for Avacta's AffiDX(R) SARS-CoV-2 antigen lateral flow test reported in April demonstrated 100% sensitivity for identifying infectious individuals with viral loads measured by PCR of Ct<27."

Hopefully, get some good media coverage around this impressive headline.

Had a friend working as a steeple jack in Aruba for a couple of years, until he failed a ‘test’ one day (don’t know if it was lft). It’s close proximity to Colombia will give you a clue as to what substance he tested positive for. Cheap as chips he used to say. Not that way inclined myself, I might add.

If you fancy a chuckle, this was Maaaatttt's 'keeping under the radar' LSE post from last night, for anybody who missed it.
...............
Wow, ODX. I hear they do a test for food intolerance is it? Fantastic idea. That’s how all the cool kids find out they’re allergic to nuts right? A test! They shove one past their massively swollen tongue and one up their arse as they **** their pants as the lactose intolerance from the glass of milk they washed them down with kicks in. And then use their colossal swollen hands to dial for a ******* ambulance. Great idea. You must be selling loads?

Speaking of SAE, I hope you’ve invested there. They make pellets, half plastic, half who the **** cares, and they burn them for energy. Which is great since ODX have sold not a single antibody test, in fact not a single test of any description. 57 out of 100 for usability by the way. I hope you do a test for blindness because they’ll be needed after users end up ramming them in their own eyeballs after trying to follow the instructions after they were too busy ****eing themselves after their Food Intolerance test came back negative and they cracked on with the Ben And Jerry’s to read their results in time.
Ahhh but the ace up your sleeve, the AIDS test, which all the shareholders will need to take having been shafted all the way down from 125p. I’ve heard you have to wear a Johnny on each thumb just to hit buy and sell such is the bareback slamming InColinWeThrust gives all ODX shareholders. Don’t buy a Tesla?! Don’t pay your lecky bill more like it. You’ll need that money to top up your pay as you go Nokia 3210 (after you extract it out of your mum who’s jammed it on vibrate after getting turned on while completing Snakes; bring lube, she’s drier than a dead dingos dick) so you can call your bank for an overdraft extension.

Here’s the serious bit. 47m in the bank. The best LFT. Capacity gifted from GAD. BBI. ABDX. Astrea. Biokit. LG (400m) Daewoong (7.8m series A). Ava6000 heading to clinic this year. 3 IPs. Affimers. TMAC. PreCISION. £250bn. (BILLION) addressable markets.

You’re a clown. Desperate. You’re 50% down at #ODX. Good luck waiting for a 100% day to get back to your highs.

Lots of love. DOH85

See what you mean now D-G. Perhaps it's something you can buy at the local chemist. Other than that you might have to buy a minimum order qty of something like 5000 from Mologic :-) Christmas present for Mrs D-G?

Why do you say it's still not possible to buy the peritonitis?
It's on the Mologic website as a CE marked self-test.

https://mologic.co.uk/our-core-markets-and-products/infection-and-infectious-disease/periplex/

For UK Sales enquiries please contact us
If you are outside the UK and wish to purchase the PERiPLEX kit, please contact our regional distributors:

Seems fairly obvious, looking at other company entries, that the date registered ('26/11/2019') is when the company first registered with MHRA and the MHRA reference code is the code given to that company at first registration. They don't give a device registration date, neither do they assign a reference code to each device.

Doesn't give the actual 'name' of the test on there Timster.
"SARS-CoV-2 antigen IVD kit immunochromatographic test (ICT) rapid" is just a test classification.
So, it could be Avacta.
But also could be Aptamer or Mologic.

Maybe we'll get half the approval today and half next week, then.

Thank you wyn, I feel the warm embrace. Go on, I dare you say it, a break out is looming large :-)

Good article here for anybody wanting to refamiliarise themselves with the MHRA/Innova story.
https://www.soundhealthandlastingwealth.com/health-news/coronavirus-uk-doh-rebrands-professional-kits-as-nhs-self-tests/

Thank you for confirming the obvious.

Yes, that £400k GDR sold was to enable Beckman to tout them around the states. That was a good few months back. Have you heard anything back from them, you know, there being a worldwide shortage of PCR tests and all that?

According to EU database, the Innova test is CE marked.
https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/1801

[I am the same as you, its more likely to rebound off this strong support than fall through, but it might, that's the downside, the upside is a break over 241p and as I said "WE ARE AWAY".]

Would have been nice to hear you describe it that way yesterday wyn, rather than the 214 support level looming large. Thanks for the update anyway.